GlassScriptPhysician profile
Judy Rivera
NPI 1316697675
$477.63
in general payments reported to CMS, 2019-2025
13 companies · $227 in 2025
The $227 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $47.07 · 2024: $204 · 2025: $227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $85.25 | 2023-2025 | Trelegy Ellipta |
| Ardelyx, INC. | $63.28 | 2024-2025 | Ibsrela |
| Novo Nordisk INC | $53.75 | 2024-2025 | Ozempic, Wegovy, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $33.17 | 2023-2024 | Farxiga |
| Lilly USA, LLC | $33.01 | 2024-2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $32.80 | 2024 | |
| Phathom Pharmaceuticals, INC. | $32.39 | 2025 | Voquezna |
| Scilex Pharmaceuticals INC. | $30.92 | 2023-2024 | Ztlido |
| Kowa Pharmaceuticals America, INC. | $28.64 | 2025 | Zoryve |
| Exact Sciences Corporation | $26.56 | 2025 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $23.05 | 2025 | Lagevrio |
| Pfizer INC. | $19.00 | 2025 | |
| Guard Medical INC. | $15.81 | 2024 | Npseal Large |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judy Rivera listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.